In addition, we reported that RUNX1 regulates ErbB2/HER2 signaling pathway in HER2‐positive gastric cancer cells through transactivating SOS1 expression, rendering itself an ideal target for antitumor strategy toward this cancer. The gene discussed is ERBB2; the disease is cancer.